Physician profile
Kevin J Chaisson
NPI 1407817836
$1,658.47
in general payments reported to CMS, 2019-2025
16 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $99.35 · 2021: $95.18 · 2022: $219 · 2023: $119 · 2024: $355 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.43 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $624.60 | 2019-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Abbvie INC. | $174.55 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $131.54 | 2019-2023 | |
| Oyster Point Pharma, INC. | $118.17 | 2022-2025 | Tyrvaya, Ryzumvi |
| Aerie Pharmaceuticals, INC. | $111.96 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $108.64 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $92.08 | 2023-2024 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.17 | 2019 | |
| Coopervision INC. | $34.82 | 2019-2020 | |
| Biotissue Holdings INC. | $33.53 | 2025 | |
| Astellas Pharma US INC | $31.47 | 2024 | Izervay |
| Johnson & Johnson Vision Care, INC. | $25.31 | 2019-2020 | |
| Genentech USA, INC. | $24.48 | 2024 | Vabysmo |
| Thea Pharma INC. | $22.55 | 2024 | Iyuzeh |
| Menicon America INC | $20.73 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $17.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chaisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.